15 search results
- Current search:
- Has podcast
- Kidney disease
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
Cochrane EvidencePublished 5 Jul 2016
The accuracy of two imaging tests in detecting vesicoureteral reflux
Some children are born with an anatomic abnormality that allows backwards flow of urine from the bladder to the kidney. This is called vesicoureteral reflux or VUR. Children with VUR have more urinary tract infections and develop more renal scars than children without VUR. This is especially the case if VUR is severe. As such, clinicians are interested ... -
Cochrane EvidencePublished 7 Jan 2016
Pre-emptive correction of stenosis of the arteriovenous access for haemodialysis
An arteriovenous access consists of a direct surgical connection between an artery and a vein in the arm (fistula) or a plastic conduit connecting an artery and a vein (graft). If these forms of access become dysfunctional the delivery of dialysis therapy becomes suboptimal. The most common cause of access dysfunction is the development of a restriction ... -
Cochrane EvidencePublished 24 Sep 2015
Interventions for renal vasculitis in adults
Renal vasculitis presents as rapidly progressive glomerulonephritis which is a form of kidney disease that causes damage to the small structures (glomeruli) inside the kidneys that help filter waste and fluids from blood to form urine. The disease leads to a rapid loss of kidney function. Standard suppression of the immune system with steroids and cyclophosphamide ... -
Cochrane EvidencePublished 3 Aug 2015
Immunosuppressive agents for treating IgA nephropathy
IgA nephropathy is a common kidney disease that often leads to decreased kidney function and may result ultimately in kidney failure for one-third of affected people. The cause of IgA nephropathy is not known, although most people with the disease have abnormalities in their immune system. We identified 32 studies enrolling 1781 patients that met our ... -
Cochrane EvidencePublished 14 Jul 2015
Which therapies are the most effective to prevent the progression of autosomal dominant polycystic kidney disease?
Current clinical care for people who have autosomal dominant polycystic kidney disease (ADPKD) focuses on controlling future risks for need for dialysis and symptom management, mainly pain and bleeding. Newly discovered molecules that may slow kidney cyst growth has recently switched attention from care and treatment toward preventing disease progression ... -
Cochrane EvidencePublished 20 May 2015
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease
People who have severe loss of kidney function are treated with dialysis or a kidney transplant to remove toxins and fluid. Dialysis removes waste products and fluid by filtering these across a membrane in the dialysis machine (for haemodialysis) or within the body (for peritoneal dialysis). Toxins that build-up in the body when the kidneys fail vary ... -
Cochrane EvidencePublished 18 Mar 2015
Corticosteroid therapy for children with nephrotic syndrome
Nephrotic syndrome is a condition where the kidneys leak protein from the blood into the urine. When it is untreated, children can often die from infections. Most children, with nephrotic syndrome, respond to corticosteroid drugs (prednisone, prednisolone) reducing the risk of serious infection. However they usually have repeat episodes, which are often ... -
Cochrane EvidencePublished 8 Dec 2014
The relative safety and effectiveness of different epoetin drugs for treating anaemia in people with chronic kidney disease
Several drugs are available to treat anaemia for people who have kidney disease but whether these drugs are similar or different in their ability to improve symptoms of anaemia, such as tiredness and breathlessness, and whether they are equally safe based on their risks of causing a stroke or a heart attack, is not clear. This is because research studies ... -
Cochrane EvidencePublished 12 Dec 2012
Treatment for people with lupus nephritis
Lupus nephritis is an inflammatory condition affecting the kidneys which is caused by systemic lupus erythematosus (SLE), an autoimmune disease that is more common among women. About half of all people with SLE develop lupus nephritis, and of these about 1/10 experience chronic kidney disease or kidney failure. Treatment aims to delay disease progression ... -
Cochrane EvidencePublished 17 Oct 2012
Cranberries for preventing urinary tract infections
Cranberries (usually as cranberry juice) have been used to prevent urinary tract infections (UTIs). Cranberries contain a substance that can prevent bacteria from sticking on the walls of the bladder. This may help prevent bladder and other UTIs. This review identified 24 studies (4473 participants) comparing cranberry products with control or alternative ...
